Fundraising FoxFirst Analysis — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Dina operates a care coordination platform that connects patients, providers, technology and data to improve access to care and coordinate communication after hospital discharge.
AI & Machine LearningDigital HealthHealthtechSaaSChicago, US
Ashish Shah(Chief Executive Officer)inDavid Coyle(Director)in
BoardSean Dowling(Director)in
Co-investorsFirst Trust Capital PartnersOsage Venture PartnersChicago VenturesMeridian Street Capital
Applied StemCell is a genome engineering platform company that develops proprietary technologies and iPSC expertise to enable safe, scalable integration of large DNA payloads into the mammalian genome for gene and cell-based medicine.
BiotechDeep TechMedical DevicesMilpitas, US
Dolores Baksh(Chief Executive Officer)inRuhong Jiang(Executive Officer, Director)Guoliang Yu(Director)
BoardZhenyu Xiao(Director)
Sware offers the GxP Suite, a SaaS validation platform (Res_Q) that uses AI agents to manage software, plant/equipment, and medical device validation while maintaining audit readiness.
AI & Machine LearningHealthtechSaaSChelsea, US
Bryan Ennis(Co-Founder & Chief Quality Officer)inEllen Reilly(Chief Executive Officer)inTheresa Pauzer(Chief People Officer)inEvan Raggi(Chief Commercial Officer)in
BoardKOSAL KEO(Director)WILLIAM R. COWEN(Director)in
Co-investorsInsight PartnersJumpstart CapitalNew Stack VenturesSimplex VenturesLRVHealth
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.